AI & ChatGPT searches , social queries for GLPG1205
Search references for GLPG1205. Phrases containing GLPG1205
See searches and references containing GLPG1205!
Search references for GLPG1205. Phrases containing GLPG1205
See searches and references containing GLPG1205!GLPG1205
Pharmaceutical compound
GLPG1205 is an experimental drug which acts as a selective antagonist (or perhaps negative allosteric modulator) at the free fatty acid receptor GPR84
GLPG1205
Belgian pharmaceutical research company
the treatment of rheumatoid arthritis and potentially Crohn's disease. GLPG1205: a first-in-class GPR84-inhibitor currently under research for the treatment
Lakefront_Biotherapeutics
Belgian pharmaceutical company
anti-inflammatory drug candidate GLPG1690 as well as two other compounds including GLPG1205 (a first-in-class inhibitor of GPR84). In May 2016, the company launched
Janssen_Pharmaceuticals
Index of chemical compounds with the same molecular formula
molecular formula C22H22N2O3 (molar mass: 362.429 g/mol) may refer to: ML-SA1 GLPG1205 This set index page lists chemical structure articles associated with the
C22H22N2O3
Protein-coding gene in the species Homo sapiens
GPR84. Further work is needed to confirm this hypothesis. The molecule GLPG1205, a selective GPR84 antagonist, was under investigation by the Belgian firm
GPR84
GLPG1205
GLPG1205
GLPG1205
GLPG1205
GLPG1205
GLPG1205
GLPG1205
GLPG1205
GLPG1205